The Department of Neurology now has two districts in the Headquarter and Shangjin Branch, 4 wards with more than 300 beds, 55 doctors and 97 nurses, including 26 professors and associate professors, 2 chief nurses, 6 doctoral tutors, and 15 master tutors. It is the diagnosis & treatment center of complicated and severe neurological diseases in Southwestern China, taking a lead in the field at home and abroad.
In 2013, the Department treated 280,000 outpatients, with a monthly average of 22,000. More than 13,000 patients were discharged every year, with over 1,000 discharged monthly. The multiple subspecialties and overall-nursing model management have been established and developed in cerebrovascular diseases, epilepsy and seizure diseases, dyskinesia diseases, demyelinating and spinal diseases, cognitive dysfunction diseases, peripheral nerve and muscle diseases, central nervous system infections, encephalopathy, and severe and complicated diseases of the nervous system and miscellaneous diseases.
The Department of Neurology has achieved remarkable results in the studies of cerebrovascular disease, epilepsy, neuro-genetic degeneration and neuro-immunological diseases, at an advanced level domestically and internationally. In the past 5 years, nearly 400 academic papers have been published, with nearly 200 research papers included in SCI, including high-impact SCI journals of “NEJM”, “JAMA”, “Lancet Neurology”, “Neurology”, “Stroke”, etc. This Department has obtained 2 key specialty construction funds from the National Health and Family Planning Commission, and 25 from National Natural Science Foundation; it has gained twice the first prize of the Natural Science Award of the Ministry of Education.
The Department of Neurology has deepened its teaching reforms in a long run. In 2010, it integrated teaching courses in neurology, neurosurgery, psychiatry, and neuroanatomy to build a multidisciplinary and interdisciplinary teaching platform, which has greatly improved the teaching quality and efficiency. In 2012, it won the first prize of teaching achievements of Sichuan University. And it has edited and co-edited 10 textbooks and monographs on neurology.
Subspecialty of Cerebrovascular Disease: The subspecialty is the largest diagnosis & treatment center of the cerebrovascular disease in Western China, the director of the World Stroke Organization (WSO) (the earliest in mainland China), a member of Cerebrovascular Disease Working Group of the World Health Organization (WHO) (the only in China), and the leader of the Cerebrovascular Disease Group of the Chinese Medical Association Neurology Branch. It was the first to systematically carry out evidence-based research on stroke-specific therapies in China, providing useful evidences for standardized treatment of cerebrovascular disease in China as it has been cited by multiple international guidelines.
Specialty Group of Epilepsy and Seizures: It dedicates to the diagnosis & treatment of epilepsy and other non-epileptic seizure diseases (such as seizure syncope, convulsions, dizziness, behavioral abnormalities, etc.), with 15 video-EEG monitoring beds, 30 hospital beds, of which 2 are for severe cases. And it serves more than 30,000 patients annually, and becomes a national leader in the diagnosis & treatment of refractory epilepsy.
Specialty Group of Neuro-immunology: It conducts clinics on neuro-immunity, covering multiple sclerosis, optic neuro-myelitis spectrum diseases, myasthenia gravis, Guillain-Barre syndrome and other diseases, with about 20 beds and 3600 outpatients every year. Following the principles of comprehensive management and prevention, it has brought the convenience to patients with neuro-immunity in Western China.
Specialty Group of Neurodegenerative Disease: It dedicates to fundamental, clinical, and imaging studies of neurodegenerative diseases, including Parkinson's disease, moto-neuron disease, multiple-system atrophy, Huntington's disease, hereditary spastic paraplegia, and dystonia, etc.
Specialty of Neuromuscular Disease: With extensive experience in the diagnosis & treatment of peripheral neuropathy and muscle disease, it has developed individualized diagnosis&-treatment programs, fully combining clinical manifestations, examinations of traditional electromyography and muscle pathology, and emerging gene-sequencing technologies; it has undertaken the treatment of clinical diseases in complicated neuromuscular, meanwhile it has accumulated a wealth of data in clinical, pathological and genetic research.
Specialty of Neurocognitive Disorders: With extensive experience in the diagnosis & treatment of neuropsychological and cognitive disorders, it has developed an individualized diagnosis-treatment plan by combining the clinical neuropsychological assessments, the neuroimaging (such as MRI, PET-CT), the pathological examination and genetic testing and other techniques, and has undertaken the treatment of clinical problems of complex neuropsychological and cognitive disorders in the region, meanwhile it has accumulated rich data in the clinical, pathological and genetic research, involving all kinds of cognitive disorders such as Alzheimer's disease, vascular dementia, frontotemporal dementia, and leukemia.
